Expansion System for Clinical Manufacture of Cellular Immunotherapies
LISTED UNDER:
The Xuri technology family from GE Healthcare Life Sciences is a new technology family designed specifically to support and advance the field of cell therapy. This new technology family, in which the first product is the Xuri Cell Expansion System W25 for the manufacture of cellular immunotherapies in a clinical setting, will combine GE Healthcare’s capabilities in cellular science with the company’s expertise in the development of advanced tools for the manufacture of biopharmaceuticals. The Xuri Cell Expansion System W25 is a functionally closed, automated system, specifically designed to be suitable for the requirements of scaling-out cell therapies in a clinical setting. The system is equipped with dedicated software applications to make it suitable for a regulated manufacturing environment and has been validated for T-cell growth. The Xuri W25 builds on the company’s WAVE bioreactor technology, which is used in the development and manufacture of biopharmaceuticals.
GE Healthcare Life Sciences, www.gehealthcare.com
